Developing antibodies designed to prevent serious infectious diseases.
Industry: Health Care
First Day Return: +40.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/20/2017 |
Offer Price | $10.00 |
Price Range $10.00 - $10.00 | |
Offer Shares (mm) | 4.0 |
Deal Size ($mm) | $40 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/15/2017 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $40 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2010 |
Employees at IPO | 39 |
Website www.arsanis.com |